156 related articles for article (PubMed ID: 17455999)
1. Palladin mutation causes familial pancreatic cancer: absence in European families.
Slater E; Amrillaeva V; Fendrich V; Bartsch D; Earl J; Vitone LJ; Neoptolemos JP; Greenhalf W
PLoS Med; 2007 Apr; 4(4):e164. PubMed ID: 17455999
[No Abstract] [Full Text] [Related]
2. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
[TBL] [Abstract][Full Text] [Related]
3. Absence of deleterious palladin mutations in patients with familial pancreatic cancer.
Klein AP; Borges M; Griffith M; Brune K; Hong SM; Omura N; Hruban RH; Goggins M
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1328-30. PubMed ID: 19336541
[TBL] [Abstract][Full Text] [Related]
4. PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
Liotta L; Lange S; Maurer HC; Olive KP; Braren R; Pfarr N; Burger S; Muckenhuber A; Jesinghaus M; Steiger K; Weichert W; Friess H; Schmid R; Algül H; Jost PJ; Ramser J; Fischer C; Quante AS; Reichert M; Quante M
JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33764904
[TBL] [Abstract][Full Text] [Related]
5. [Familial pancreatic cancer and the palladin gene: a new look at cancer mechanisms].
Gilgenkrantz S
Med Sci (Paris); 2007 Mar; 23(3):232-4. PubMed ID: 17349274
[No Abstract] [Full Text] [Related]
6. Familial pancreatic-cancer gene found.
Bradbury J
Lancet Oncol; 2007 Jan; 8(1):14. PubMed ID: 17348120
[No Abstract] [Full Text] [Related]
7. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer.
Zogopoulos G; Rothenmund H; Eppel A; Ash C; Akbari MR; Hedley D; Narod SA; Gallinger S
Hum Genet; 2007 Jun; 121(5):635-7. PubMed ID: 17415588
[TBL] [Abstract][Full Text] [Related]
8. Familial pancreatic cancer: hope can become truth.
Pezzilli R; Fantini L
JOP; 2007 Jan; 8(1):64-6. PubMed ID: 17228136
[No Abstract] [Full Text] [Related]
9. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion.
Brentnall TA; Lai LA; Coleman J; Bronner MP; Pan S; Chen R
PLoS One; 2012; 7(1):e30219. PubMed ID: 22291919
[TBL] [Abstract][Full Text] [Related]
10. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the 4q32-34 locus in European familial pancreatic cancer.
Earl J; Yan L; Vitone LJ; Risk J; Kemp SJ; McFaul C; Neoptolemos JP; Greenhalf W; ; Kress R; Sina-Frey M; Hahn SA; Rieder H; Bartsch DK;
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1948-55. PubMed ID: 17035404
[TBL] [Abstract][Full Text] [Related]
12. PALB2 mutations in European familial pancreatic cancer families.
Slater EP; Langer P; Niemczyk E; Strauch K; Butler J; Habbe N; Neoptolemos JP; Greenhalf W; Bartsch DK
Clin Genet; 2010 Nov; 78(5):490-4. PubMed ID: 20412113
[TBL] [Abstract][Full Text] [Related]
13. Isoform-specific upregulation of palladin in human and murine pancreas tumors.
Goicoechea SM; Bednarski B; Stack C; Cowan DW; Volmar K; Thorne L; Cukierman E; Rustgi AK; Brentnall T; Hwang RF; McCulloch CA; Yeh JJ; Bentrem DJ; Hochwald SN; Hingorani SR; Kim HJ; Otey CA
PLoS One; 2010 Apr; 5(4):e10347. PubMed ID: 20436683
[TBL] [Abstract][Full Text] [Related]
14. Disruption of palladin results in neural tube closure defects in mice.
Luo H; Liu X; Wang F; Huang Q; Shen S; Wang L; Xu G; Sun X; Kong H; Gu M; Chen S; Chen Z; Wang Z
Mol Cell Neurosci; 2005 Aug; 29(4):507-15. PubMed ID: 15950489
[TBL] [Abstract][Full Text] [Related]
15. Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression.
Cannon AR; Owen MK; Guerrero MS; Kerber ML; Goicoechea SM; Hemstreet KC; Klazynski B; Hollyfield J; Chang EH; Hwang RF; Otey CA; Kim HJ
Cytoskeleton (Hoboken); 2015 Aug; 72(8):402-11. PubMed ID: 26333695
[TBL] [Abstract][Full Text] [Related]
16. The role of palladin in actin organization and cell motility.
Goicoechea SM; Arneman D; Otey CA
Eur J Cell Biol; 2008 Sep; 87(8-9):517-25. PubMed ID: 18342394
[TBL] [Abstract][Full Text] [Related]
17. Akt2 regulates expression of the actin-bundling protein palladin.
Chin YR; Toker A
FEBS Lett; 2010 Dec; 584(23):4769-74. PubMed ID: 21050850
[TBL] [Abstract][Full Text] [Related]
18. Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomas.
Henderson-Jackson EB; Helm J; Strosberg J; Nasir NA; Yeatman TJ; Kvols LK; Coppola D; Nasir A
Anticancer Res; 2011 Sep; 31(9):2957-62. PubMed ID: 21868544
[TBL] [Abstract][Full Text] [Related]
19. Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin.
Rachlin AS; Otey CA
J Cell Sci; 2006 Mar; 119(Pt 6):995-1004. PubMed ID: 16492705
[TBL] [Abstract][Full Text] [Related]
20. The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration.
Chin YR; Toker A
Mol Cell; 2010 May; 38(3):333-44. PubMed ID: 20471940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
